Charles H. Bennett and Gilles Brassard on the collaboration that led them to the 2025 ACM A.M. Turing Award.
NRG-LU002: Randomized phase II/III trial of maintenance systemic therapy versus local consolidative therapy (LCT) plus maintenance systemic therapy for limited metastatic non-small cell lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results